Cipher Pharmaceuticals Risk Adjusted Performance
| CPH Stock | | | CAD 16.68 -0.15 -0.89% |
Observed values used in the Risk Adjusted Performance indicator for Cipher Pharmaceuticals are included in this dataset. Market data gaps can influence the computed indicator values. Cipher Pharmaceuticals has a market cap of 423.17 M, operating margin of 36.22%, current ratio of 1.06. Use
Trending Equities to explore allocation context. Tracking Cipher Pharmaceuticals in a portfolio provides context for performance attribution. All values are presented as reference data. Broader economic conditions can influence Cipher Pharmaceuticals's company valuation — related indicators include
signals in state.
Cipher Pharmaceuticals has current Risk Adjusted Performance of 0.0752.
RAP | = | (ER[a] - RFR) * STD[b])/STD[b]RFR |
| = | 0.0752 | |
Risk Adjusted Performance Peers Comparison
Risk Adjusted Performance Relative To Other Indicators
Cipher Pharmaceuticals lands at
#2 in risk adjusted performance compared to key competitors. It is currently under evaluation in maximum drawdown compared to key competitors producing
273.34 in Maximum Drawdown for each unit of Risk Adjusted Performance. The spread between Maximum Drawdown and Risk Adjusted Performance for Cipher Pharmaceuticals sits at
273.34 Other Technical Indicators